Author
InsermORCID 0000-0003-4814-6722Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
4 papers
Recent·Most cited
Maeva Y. Chauvin, Julien Roche-Prellezo, Virginie Lafont…·David Pépin
This study identifies cancer-associated mesothelial cells (CAMCs) as drivers of immune escape and therapy resistance in ovarian cancer by altering immune cell infiltration and function.
Laura Morano, Nadia Vié, Adam Aissanou…·Jihane Basbous
This study identifies TopBP1 condensation inhibitors, showing AZD2858 disrupts ATR signaling and synergizes with chemotherapy in colorectal cancer.
Maeva Y. Chauvin, Estelle Tromelin, Julien Roche-Prellezo…·David Pépin
This study identifies FSTL3 as a biomarker of poor prognosis and immunotherapy resistance in ovarian cancer, showing its role in promoting a mesenchymal phenotype and immunosuppressive microenvironment.
Ghita Chabab, Henri‐Alexandre Michaud, Cécile Déjou…·Virginie Lafont
The paper identifies a higher density of CD73+ γδ T cells in ovarian cancer tumors from patients with poor survival, describing their pro-tumor ecosystem.